COUMERMYCIN
Coumermycin A1
CAS: 4434-05-3
Molecular Formula: C55H59N5O20
COUMERMYCIN - Names and Identifiers
| Name | Coumermycin A1 |
| Synonyms | coumamycin notomycina1 Coumermycin coumermycins Notomycin A1 COUMERMYCIN A1 Coumermycin A1 l)oxy)-4-hydroxy-8-methylcoumarin) pyrrole-2-carboxylicacid,5-methyl-,diesterwith3,3'-((3-methylpyrrole-2,4-d iyl)bis(carbonylimino))bis(7-((5,5-di-c-methyl-4-o-methyl-alpha-l-lyxopyranosy |
| CAS | 4434-05-3 |
COUMERMYCIN - Physico-chemical Properties
| Molecular Formula | C55H59N5O20 |
| Molar Mass | 1110.08 |
| Density | 1.1866 (rough estimate) |
| Melting Point | 259°C (rough estimate) |
| Boling Point | 821.5°C (rough estimate) |
| Solubility | DMSO: 50mg/mL, clear, faintly yellow |
| Appearance | Solid |
| BRN | 470805 |
| pKa | pKa 6.0±0.02(H2O ) (Uncertain) |
| Storage Condition | 2-8°C，密封，干燥 |
| Refractive Index | 1.7210 (estimate) |
| In vitro study | Coumermycin A1-induced-JAK2 signal activation increases the mRNA level of SCOS2, but reducea leptin receptor mRNA level. |
COUMERMYCIN - Risk and Safety
| Hazard Symbols | Xn - Harmful |
| Risk Codes | 22 - Harmful if swallowed |
| Safety Description | 36 - Wear suitable protective clothing. |
| WGK Germany | 3 |
| RTECS | UX9375000 |
| FLUKA BRAND F CODES | 10-21 |
